Chih-Hsiang Leng Selected Research

HLA-A11 Antigen

11/2009

Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chih-Hsiang Leng Research Topics

Disease

17	Neoplasms (Cancer) 01/2019 - 11/2009
8	Dengue (Dengue Fever) 01/2016 - 02/2009
3	Communicable Diseases (Infectious Diseases) 01/2019 - 08/2010
3	Viremia 02/2016 - 03/2014
3	Infections 01/2016 - 07/2007
3	Virus Diseases (Viral Diseases) 01/2015 - 02/2009
3	Human Influenza (Influenza) 08/2010 - 05/2009
3	Severe Acute Respiratory Syndrome 07/2007 - 04/2006
2	Inflammation (Inflammations) 08/2015 - 01/2015
2	Diarrhea 08/2015 - 01/2015
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2014 - 01/2014
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Cross Infection (Nosocomial Infection) 08/2015
1	Clostridium Infections 08/2015
1	Colitis 01/2015
1	Opportunistic Infections (Opportunistic Infection) 01/2015
1	Meningococcal Meningitis 11/2010

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 01/2019 - 08/2010
10	VaccinesIBA 01/2019 - 05/2009
7	Peptides (Polypeptides)IBA 03/2015 - 07/2007
5	Proteins (Proteins, Gene)FDA Link 11/2016 - 04/2006
4	Lipoproteins (Lipoprotein)IBA 10/2016 - 03/2014
4	Toll-Like Receptor 2IBA 05/2016 - 03/2014
4	Neutralizing AntibodiesIBA 02/2016 - 07/2013
4	Subunit VaccinesIBA 01/2015 - 01/2011
3	Combined VaccinesIBA 01/2016 - 02/2009
3	LipidsIBA 01/2015 - 03/2014
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 01/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 11/2016
2	Recombinant ProteinsIBA 04/2016 - 01/2015
2	aluminum sulfate (alum)IBA 02/2016 - 02/2014
2	Dengue VaccinesIBA 01/2016 - 02/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2015 - 01/2015
2	trimethylaminocarboxyldihydroboran (TCDB)IBA 08/2015 - 01/2015
2	Glycoproteins (Glycoprotein)IBA 08/2015 - 01/2015
2	OligodeoxyribonucleotidesIBA 03/2014 - 01/2014
2	LipopeptidesIBA 01/2014 - 08/2011
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020
1	E-SelectinIBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	SurvivinIBA 01/2018
1	Liposomes (Liposome)IBA 10/2016
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 10/2016
1	FlagellinIBA 04/2016
1	Gemcitabine FDA Link 03/2016
1	Pharmaceutical PreparationsIBA 03/2016
1	Programmed Cell Death 1 ReceptorIBA 03/2016
1	ExotoxinsIBA 08/2015
1	Papillomavirus Vaccines (HPV Vaccines)IBA 03/2015
1	EndotoxinsIBA 01/2015
1	CPG-oligonucleotideIBA 03/2014
1	Toll-Like Receptor 9IBA 03/2014
1	Toll-Like Receptor AgonistsIBA 03/2014
1	Ethylene Glycol (Monoethylene Glycol)IBA 02/2014
1	poly(lactide) (polylactic acid)IBA 02/2014
1	squalaneIBA 02/2014
1	EmulsionsIBA 01/2014
1	EpitopesIBA 01/2014
1	Protein Subunit VaccinesIBA 01/2014
1	aluminum phosphateIBA 07/2013
1	HLA-A11 AntigenIBA 11/2009
1	Hemagglutinins (Hemagglutinin)IBA 05/2009
1	Protein SIBA 07/2007
1	Synthetic Vaccines (Recombinant Vaccines)IBA 07/2007
1	Amino Acids FDA Link 07/2007
1	HLA-A*02:01 antigenIBA 05/2006
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 05/2006
1	Urea (Carbamide)FDA LinkGeneric 04/2006

Therapy/Procedure

9	Immunotherapy 01/2019 - 01/2014
4	Therapeutics 05/2016 - 03/2014
1	Treatment Delay 10/2016
1	Drug Therapy (Chemotherapy) 03/2016